Recent Projects and Leadership Roles
We are honored to have been entrusted with vital leadership roles that have had significant impact on the boards and businesses they serve, with a representative list below.
FEATURED PLACEMENTS
HALOZYME
VP, Chief Information Officer
Engrail Therapeutics
Chief Financial Officer
FATE THERAPEUTICS
Independent Director
Avidity Biosciences
Independent Director
CARGO Therapeutics
VP, Regulatory Affairs
EyePoint Pharmaceuticals
Chief Medical Officer
| Cardiff Oncology | Independent Director (2) |
| Carina Biotech | Independent Director (2) |
| Fate Therapeutics | Independent Director |
| Histogen | Independent Director (2) |
| Illumina | Independent Director (3) Ethics Advisory Board |
| Mammogen | Independent Director |
| Pliant Therapeutics | Independent Director (2) |
| SioGene Therapies | Independent Director |
| Vaxxinity | Independent Director |
| Alexion | Chief Medical Officer |
| Alovant | President and Chief Operating Officer |
| Ascensia | Chief Medical Officer |
| Aviwell | Chief Executive Officer & Director |
| Bexion Pharmaceuticals | Chief Executive Officer & Director Chief Financial Officer |
| BioLA | Chief Executive Officer |
| Brickell Biotech | Chief Medical Officer |
| Cardiff Oncology | Chief Scientific Officer |
| Cellectis | Chief Medical Officer |
| Cellics | Chief Executive Officer & Director |
| Confidential | Chief Financial Officer |
| Corsair | Chief Executive Officer |
| Critical Path Institute | Chief Executive Officer & Director |
| Dermavant Sciences | Chief Scientific Officer |
| Engrail | CSO and SVP of Development, Chief Financial Officer |
| Exciva | Chief Executive Officer & Director |
| Fate Therapeutics | Chief Medical Officer |
| Gallant | Chief Executive Officer & Director |
| Glenmark | Chief Commercial Officer |
| Halozyme | Chief Information Officer |
| Imagion | Chief Development Officer |
| Inivata, Inc. | Chief Medical Officer |
| LabCentral | Chief People Officer |
| Lineage Cell Therapeutics | Chief Executive Officer & Director |
| Mammogen | Chief Executive Officer & Director |
| Neuraptive | Chief Operating Officer and EVP, Head of R&D |
| New Rhein | Managing Partner & Chief Medical Officer |
| Onchilles | Chief Scientific Officer |
| Pierian | Chief Executive Officer & Director |
| Poseida | President, Gene Therapy President, Cell Therapy |
| Sanofi | Chief Patient Officer |
| Symbio Pharmaceuticals | Chief Executive Officer |
| United Bomedical | EVP, Research & Development |
| United Neuroscience | Chief Scientific Officer |
| Valavant | Chief Executive Officer & Director |
| 3T Biosciences | Head of Finance |
| Accent Therapeutics | Head of Biology |
| Adaptimmune | VP, Clinical Development |
| Advaxis | VP, Medical |
| Alexion | SVP, Medical Affairs Country Leader VP, Clinical Development Neurology,br> VP, Quality Operations |
| Almatica | VP, Regulatory Affairs |
| Amicus | SVP, Clinical Research, Gene Therapy Global Head of Medical Affairs |
| Ascensia | Global Head, Clinical Development & Operations |
| Atyr | VP, Regulatory Affairs |
| Bayer Healthcare | Therapeutic Head, Cardiovascular Head of Development Center, Skincare Country Head France, BAH Pricing Market Access EU |
| Becton Dickinson | VP, Medical Affairs (4) |
| Beigene | SVP, Global Head Business Development VP, Alliance Project VP, Global Clinical Operations VP, Head of Europe Medical Affairs,br> VP, Head of Late Stage Development |
| Blueprint Medicines | VP, Biology VP, Translational Medicine |
| Cardiff Oncology Inc. | SVP, Regulatory Affairs |
| Cellectis | SVP, Regulatory Affairs |
| Clovis | VP, Safety & Pharmacovigilance |
| Embecta (subsidiary of BD) | Global Head Medical, Clinical and Scientific Affairs & Chief Medical Officer |
| EyePoint Pharmaceuticals | Senior VP, Program Leadership |
| Fate Therapeutics | SVP, Corporate Development SVP, Technical Operations VP, Clinical Development (3) VP, Solid Tumor Biology |
| Glenmark | VP, Market Access |
| Halozyme | VP, Chief Information Officer |
| Humacyte Inc. | VP, Scientific & Medical Communications |
| Idorsia | Clinical Lead – Neurology |
| Insmed | SVP, Head of Clinical Development |
| Intellectual Ventures | Commercial Lead, Medical Technologies |
| Intercept | VP, Regulatory Affairs, R&D |
| Jasper Therapeutics | VP, Clinical Operations |
| Johnson & Johnson | VP, Biologics Discovery Head, J&J Innovation West NA, Australia & New Zealand |
| LabCentral | Executive Director, Ignite |
| Myovant | SVP, Pharma. Operations and Development |
| Nutrinia | VP, Regulatory Affairs |
| Pfizer | VP, Development Head Immuno-Oncology Medicine Team Lead |
| Pharma Essentia | Global Head of Pharmacovigilance |
| Regeneron | Global Program Head – Oncology VP, Strategic Program Direction TA Head, Oncology VP, Global Program Head Immunology Strategic Program Director, CV/META Strategic Program Heads (2) |
| Regulus | VP, Preclinical Development |
| Sanofi | Head of Bioprocesses |
| Symbio Pharmaceuticals | SVP R&D and Global Chief Medical Officer |
| Talis BioMedical | VP, Assay Development |
| Urovant | VP, Manufacturing |
| VP, Regulatory Affairs & Quality Assurance | VP, Manufacturing |
| Urovant | VP, Manufacturing |
| Zymeworks | SVP, Research |
C-SUITE
| Alexion | Chief Medical Officer |
| Alovant | President and Chief Operating Officer |
| Ascensia | Chief Medical Officer |
| Aviwell | Chief Executive Officer & Director |
| Bexion Pharmaceuticals | Chief Executive Officer & Director Chief Financial Officer |
| BioLA | Chief Executive Officer |
| Brickell Biotech | Chief Medical Officer |
| Cardiff Oncology | Chief Scientific Officer |
| Cellectis | Chief Medical Officer |
| Cellics | Chief Executive Officer & Director |
| Confidential | Chief Financial Officer |
| Corsair | Chief Executive Officer |
| Critical Path Institute | Chief Executive Officer & Director |
| Dermavant Sciences | Chief Scientific Officer |
| Engrail | CSO and SVP of Development Chief Financial Officer |
| Exciva | Chief Executive Officer & Director |
| EyePoint | Chief Medical Officer |
| Fate Therapeutics | Chief Medical Officer |
| Gallant | Chief Executive Officer & Director |
| Glenmark | Chief Commercial Officer |
| Halozyme | Chief Information Officer |
| Imagion | Chief Development Officer |
| Inivata, Inc. | Chief Medical Officer |
| LabCentral | Chief People Officer |
| Lineage Cell Therapeutics | Chief Executive Officer & Director |
| Mammogen | Chief Executive Officer & Director |
| Neuraptive | Chief Operating Officer and EVP, Head of R&D |
| New Rhein | Managing Partner & Chief Medical Officer |
| Onchilles | Chief Scientific Officer |
| Pierian | Chief Executive Officer & Director |
| Poseida | President, Gene Therapy President, Cell Therapy |
| Sanofi | Chief Patient Officer |
| Symbio Pharmaceuticals | Chief Executive Officer |
| United Bomedical | EVP, Research & Development |
| United Neuroscience | Chief Scientific Officer |
| Valavant | Chief Executive Officer & Director |
BOARD & ADVISORY BOARD
| Avidity Biosciences | Independent Director |
| Cardiff Oncology | Independent Director (2) |
| Carina Biotech | Independent Director (2) |
| Fate Therapeutics | Independent Director |
| Histogen | Independent Director (2) |
| Illumina | Independent Director (3) Ethics Advisory Board |
| Mammogen | Independent Director |
| Pliant Therapeutics | Independent Director (2) |
| SioGene Therapies | Independent Director |
| Vaxxinity | Independent Director |
EXECUTIVE LEADERSHIP
| 3T Biosciences | Head of Finance |
| Accent Therapeutics | Head of Biology |
| Adaptimmune | VP, Clinical Development |
| Advaxis | VP, Medical |
| Alexion | SVP, Medical Affairs Country Leader VP, Clinical Development Neurology,br> VP, Quality Operations |
| Almatica | VP, Regulatory Affairs |
| Amicus | SVP, Clinical Research, Gene Therapy Global Head of Medical Affairs |
| Ascensia | Global Head, Clinical Development & Operations |
| Atyr | VP, Regulatory Affairs |
| Bayer Healthcare | Therapeutic Head, Cardiovascular Head of Development Center, Skincare Country Head France, BAH Pricing Market Access EU |
| Becton Dickinson | VP, Medical Affairs (4) |
| Beigene | SVP, Global Head Business Development VP, Alliance Project VP, Global Clinical Operations VP, Head of Europe Medical Affairs,br> VP, Head of Late Stage Development |
| Blueprint Medicines | VP, Biology VP, Translational Medicine |
| Cardiff Oncology Inc. | SVP, Regulatory Affairs |
| Cargo Therapeutics | VP, Regulatory Affairs |
| Cellectis | SVP, Regulatory Affairs |
| Clovis | VP, Safety & Pharmacovigilance |
| Embecta (subsidiary of BD) | Global Head Medical, Clinical and Scientific Affairs & Chief Medical Officer |
| EyePoint Pharmaceuticals | Senior VP, Program Leadership |
| Fate Therapeutics | SVP, Corporate Development SVP, Technical Operations VP, Clinical Development (3) VP, Solid Tumor Biology |
| Glenmark | VP, Market Access |
| Humacyte Inc. | VP, Scientific & Medical Communications |
| Idorsia | Clinical Lead – Neurology |
| Insmed | SVP, Head of Clinical Development |
| Intellectual Ventures | Commercial Lead, Medical Technologies |
| Intercept | VP, Regulatory Affairs, R&D |
| Jasper Therapeutics | VP, Clinical Operations |
| Johnson & Johnson | VP, Biologics Discovery Head, J&J Innovation West NA, Australia & New Zealand |
| LabCentral | Executive Director, Ignite |
| Myovant | SVP, Pharma. Operations and Development |
| Nutrinia | VP, Regulatory Affairs |
| Pfizer | VP, Development Head Immuno-Oncology Medicine Team Lead |
| Pharma Essentia | Global Head of Pharmacovigilance |
| Regeneron | Global Program Head – Oncology VP, Strategic Program Direction TA Head, Oncology VP, Global Program Head Immunology Strategic Program Director, CV/META Strategic Program Heads (2) |
| Regulus | VP, Preclinical Development |
| Sanofi | Head of Bioprocesses |
| Symbio Pharmaceuticals | SVP R&D and Global Chief Medical Officer |
| Talis BioMedical | VP, Assay Development |
| Urovant | VP, Manufacturing |
| VP, Regulatory Affairs & Quality Assurance | VP, Manufacturing |
| Urovant | VP, Manufacturing |
| Zymeworks | SVP, Research |
We make life-changing placements so our clients can change lives!®